Articles for tag: CDDR, diagnosis, evidence, factors, ICD-11, organic, schizophrenia, substances

ICD-11 SCHIZOPRENIA

The ICD-11 Clinical Descriptions and Diagnostic Requirements (CDDR) sets out the diagnostic criteria for schizophrenia under code 6A20 with admirable clarity. At least two symptoms from a list of seven, at least one drawn from the core positive group — persistent delusions, persistent hallucinations, disorganised thinking, or experiences of influence, passivity, or control. Symptoms present most of the time for one month or more. And then, at the end of the essential features, a single sentence: the symptoms must not ...

Assessing Formal Thought disorder in practice

Formal thought disorder (FTD) assessment in real-world psychiatric practice is in trouble. If you work in the NHS, you will have seen it: the words “No formal thought disorder” written in a clinical note, with no accompanying evidence that any such assessment actually took place. No verbatim speech. No description of the flow of thought. No record of subjective phenomena. Just a checkbox. Non-psychiatrists who are knowledgeable about the TALD can use it freely. They are not diagnosing. They would ...

The Last Line of Defence: Prescribing in the Gap Between Clinical Practice and Regulatory Expectation

Prescribing and a prescription are not the same thing. The prescription is the visible endpoint. A signed line. A ledger entry. A medication authorised. Prescribing is everything that must happen before that endpoint can properly be reached. A diagnosis must be formulated against recognised criteria. Authoritative clinical guidelines must be considered. Capacity must be assessed. A consent dialogue must take place, meeting the Montgomery standard of material disclosure. If the medication is unlicensed for the condition being treated, that departure ...

The Narrowing Temporal Apertures for Clozapine in Treatment-Resistant Schizophrenia

This article has not been peer reviewed. It proposes a conceptual model supported by converging observational evidence and clinical reasoning. Treatment-resistant schizophrenia affects approximately 20–30% of individuals with schizophrenia. It is characterised by inadequate response to at least two adequate trials of different antipsychotics. Clozapine remains the only antipsychotic with robust evidence of benefit in this population and is recommended as first-line treatment once treatment resistance has been identified.1 In clinical practice, clozapine initiation is frequently delayed — often by ...

Safe and Appropriate Prescribing: GMC expectations mapped

“Safe and appropriate” sits at the heart of the professional standards that govern prescribing in the UK. The General Medical Council (GMC) makes it clear that doctors must propose, prescribe, provide or manage medicines and devices only when it is safe and appropriate to do so (GMCRx – Prescribing Guidance – para 97). Nowhere in the GMC’s core guidance is there a single, self‑contained definition of either “safe” or “appropriate”. There is no further guidance on ‘how safe’ or ‘how ...

Safe Prescribing Review: The Five Gates

This work contains a downloadable PDF document below. It is a working instrument, not a policy paper; a single-page crib sheet with explanatory guidance, for structured individual or team review of prescribing. Every gate serves one closing question — what justifies continuing the medication(s) for this person today? That question is the point of the whole exercise. In everyday practice, continuation is the default. Optimising, changing or stopping medications is what requires sound clinical and legal justification. Study of Good ...

Why the Oliver McGowan Case Still Matters

On 11 November 2016, Thomas Oliver McGowan, an 18-year-old man with epilepsy, mild autism, a mild learning disability, and cerebral palsy, died at Southmead Hospital in Bristol. He had been admitted on 22 October 2016 with uncontrolled seizures. During that admission, he was sedated, intubated, and given olanzapine, an atypical antipsychotic, despite explicit warnings from his family and documented evidence of prior adverse reactions to antipsychotic medication. He developed neuroleptic malignant syndrome (NMS), suffered a catastrophic brain injury, and died. ...

The Southport Inquiry: Analysis (of Phase 1)

On 29 July 2024, Axel Rudakubana carried out a fatal knife attack at a Taylor Swift-themed dance and yoga class in Southport. Three young girls were murdered, and many other children and adults suffered grave physical and psychological harm. The event shocked the country not only because of its brutality, but because it involved a young perpetrator whose history, as later examined by the Inquiry, contained repeated signs of serious and escalating risk. The Southport Inquiry was established because the ...

Why Tom Cruise might have had a point

In June 2005, a movie star sat on a sofa and told the world that my profession was a “pseudoscience”. He called the anchor of the Today Show “glib” for defending the chemical imbalance theory. At the time, as a consultant forensic psychiatrist with the weight of the Royal College and the GMC behind me, I found it offensive. We had the manuals. We had the science. We had the authority. But that was twenty years ago. Today, looking across ...

Psychiatric Diagnoses Without Evidence and Divorced from Medical Standards of Practice: Is that okay?

What This Article Is Actually About Prof Keith Rix, a forensic psychiatrist with fifty years’ experience, has collected the court judgments where these failures were exposed. His 2025 paper in BJPsych Advances shows what happens when diagnostic habits formed in clinics meet the scrutiny of a courtroom. The results are disturbing. And they affect everyone who has ever received a psychiatric diagnosis, instructed an expert, or sat on a tribunal. Consider the following: A man loses his compensation claim because an occupational ...